Millennium Pharmaceuticals Inc – Filings and Transcripts – BamSEC

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

SEC EDGAR

Financials Filter

ended 03/31/08 Q1

ended 12/31/07 FY 2007

ended 09/30/07 Q3

ended 06/30/07 Q2

ended 03/31/07 Q1

Prospectuses and Registrations Filter

Amendment to registration of securities for employees

Amendment to registration of securities for employees

Amendment to registration of securities for employees

Amendment to registration of securities for employees

Amendment to registration of securities for employees

Ownership Filter

Calithera Biosciences, Inc.

Day One Biopharmaceuticals Inc.

Day One Biopharmaceuticals Inc.

Day One Biopharmaceuticals Inc.

Day One Biopharmaceuticals Inc.

News Filter

Takeda Completes Acquisition of Millennium

Change in Directors, Officers or Compensation, Financial Statements or Exhibits

Announces Velcade® (Bortezomib) for Injection First-Quarter 2008 U.S. Net Sales

Takeda to Acquire Millennium for US$25.00 Per Share in an All Cash Tender Offer Valued at $8.8 Billion

Material Disclosure

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Definitive proxy

Preliminary proxy

Definitive proxy

Other Filter

Notice of effectiveness

Notice of effectiveness

Notice of effectiveness

Notice of effectiveness

Notice of effectiveness